United Kingdom Lactoferrin Market Size, Share, and COVID-19 Impact Analysis, By Function (Iron Absorption, Anti-inflammatory, Intestinal Flora Protection, Antibacterial, Immune Cell Stimulation, and Antioxidant), By Application (Food Products, Infant Formula, Sports & Functional Food, Pharmaceuticals, Personal care products, and Others), and UK Lactoferrin Market Insights, Industry Trend, Forecasts to 2035

United Kingdom Lactoferrin Market Forecasts to 2035

• The United Kingdom Lactoferrin Market Size Was Estimated at USD 10732.2 Thousand in 2024
• The UK Lactoferrin Market Size is Expected to Grow at a CAGR of around 8.66% from 2025 to 2035
• The UK Lactoferrin Market Size is Expected to Reach USD 26745.6 Thousand by 2035

According to a research report published by Spherical Insights & Consulting, The UK Lactoferrin Market Size is anticipated to reach USD 26745.6 Thousand by 2035, growing at a CAGR of 8.66% from 2025 to 2035. The UK lactoferrin market is growing due to rising health awareness, demand for immune-boosting products, increasing use in cosmetics and infant nutrition, and technological advancements in extraction and product formulation.

Market Overview

The lactoferrin market in the UK involves the production, processing, and distribution of lactoferrin for use in pharmaceutical, food and beverages, cosmetics, and animal nutrition applications. Lactoferrin is an iron-binding protein present in human, cow, camel, and goat milk that is particularly important for its use in treating ailments such as stomach ulcers, diarrhea, and hepatitis C. The lactoferrin market in the UK is growing due to enhanced consumer understanding, including the antimicrobial, antiviral, and immune system boosting attributes of lactoferrin. This has increased demand for lactoferrin in dietary supplements, infant formula, and functional foods. Furthermore, increasing incidences of bacterial and viral infections, growing public health awareness, and increasing interest in preventive health care have provided impetus for this market growth. UK consumers are also interested in organic and clean-label options, and therefore, manufacturers are now using lactoferrin in their products. Additionally, the pharmaceutical and personal care industries have contributed to demand for lactoferrin as an ingredient in skin care and wound products. Technological advancements in extraction and purification have improved accessibility and affordability. The COVID-19 pandemic significantly increased interest in lactoferrin for immune support. Ongoing research continues to expand its applications across multiple sectors, enhancing its market potential and encouraging further innovation in the UK nutraceutical and healthcare industries.

Report Coverage

This research report categorizes the market for the UK lactoferrin market based on various segments and regions and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the United Kingdom lactoferrin market. Recent market developments and competitive strategies such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the United Kingdom lactoferrin market.

Driving Factors

The UK market for lactoferrin is driven by increasing knowledge of its antiviral, antibacterial, and anti-inflammation properties and health and cosmetic benefits. The rising incorporation into cosmetic and personal care products, especially for acne, and in infant formula, further assists with sustained demand. Lactoferrin use in personal care is increasing as many people in the UK have acne and are increasingly using cosmetics. With its safety clearance, the usage of lactoferrin in food, pharmaceutical, and cosmetic products is expanding, creating a future market opportunity in the United Kingdom.

Restraining Factors

A major limiting factor of the UK lactoferrin market is the high cost of production due to the complicated extraction and purification process. Furthermore, raw materials are not readily available either. Additionally, the preferred sources of lactoferrin are dairy, the supply may still be disrupted. Furthermore, products for new applications enter the market slowly because of strict regulatory or legislative requirements. These factors hamper the lactoferrin market during the forecast period.

Market Segmentation

The United Kingdom lactoferrin market share is classified into function and application.

• The iron absorption segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The United Kingdom lactoferrin market is segmented by function into iron absorption, anti-inflammatory, intestinal flora protection, antibacterial, immune cell stimulation, and antioxidant. Among these, the iron absorption segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period. The growing prevalence of iron deficiency and related conditions like anaemia affects a large segment of the UK population. Lactoferrin represents a beneficial component in dietary supplements and functional foods that may be used to address iron deficiencies because of its ability to bind and transport iron, which enhances absorption in the body.

• The infant formula segment held the highest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The United Kingdom lactoferrin market is segmented by application into food products, infant formula, sports & functional food, pharmaceuticals, personal care products, and others. Among these, the infant formula segment held the highest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. The expanding understanding of the benefits of lactoferrin for infant health. Lactoferrin is an essential part of breast milk, and is well established to help support the immune system and raise the absorptive and bioavailability of iron. With these benefits, lactoferrin is a valuable addition to infant formula, providing immune support and key nutrients to the newborn. The growth in this segment has been fuelled by the increase in working moms and continued demand for quality fortified baby formulas.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the United Kingdom lactoferrin market and a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Fonterra
• Glanbia
• Kallisti Biotech Ltd
• AOR Distribution
• Immunecare
• Aliness
• Tatura Milk Industries
• Arla Foods
• Metagenics
• Bega Bionutrients
• Others

Key Target Audience

• Investors
• Market players
• End-users
• Government Authorities
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at United Kingdom, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the United Kingdom lactoferrin market based on the below-mentioned segments:

United Kingdom Lactoferrin Market, By Function

• Iron Absorption
• Anti-inflammatory
• Intestinal Flora Protection
• Antibacterial
• Immune Cell Stimulation
• Antioxidant

United Kingdom Lactoferrin Market, By Application

• Food Products
• Infant Formula
• Sports & Functional Food
• Pharmaceuticals
• Personal care products
• Others